SavedAdd your journal

Journals / Journal of Clinical Research in Pediatric Endocrinology / 2016 / Cilt: 8 - Sayı: 4

A Critical Appraisal of Growth Hormone Therapy in Growth Hormone Deficiency and Turner Syndrome Patients in Turkey

Zehra Yavaş ABALI
FATMA FEYZA DARENDELİLER
Olcay Neyzi
Pages
490–495
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These are the most frequent two indications for GH therapy in Turkey approved by the Ministry of Health for coverage by the national insurance system.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Early detection of abnormal growth, identification of the underlying cause, and appropriate treatment of the medical condition is an important issue for children with short stature.
📊
Key Findings & Data:Growth hormone (GH) therapy is widely used in GH-deficient children and also in non-GH-deficient short stature cases who have findings conforming to certain indications.
💡
Conclusion & Impact:These are the most frequent two indications for GH therapy in Turkey approved by the Ministry of Health for coverage by the national insurance system.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Early detection of abnormal growth, identification of the underlying cause, and appropriate treatment of the medical condition is an important issue for children with short stature. Growth hormone (GH) therapy is widely used in GH-deficient children and also in non-GH-deficient short stature cases who have findings conforming to certain indications. Efficacy of GH therapy has been shown in a multitude of shortand long-term studies. Age at onset of GH therapy is the most important factor for a successful treatment outcome. Optimal dosing is also essential. The aim of this review was to focus on challenges in the early diagnosis and appropriate management of short stature due to GH deficiency (GHD) and Turner syndrome. These are the most frequent two indications for GH therapy in Turkey approved by the Ministry of Health for coverage by the national insurance system.

🔖

Cite This Article

ABALI, Z. Y., DARENDELİLER, F. F., Neyzi, O. (2016). A Critical Appraisal of Growth Hormone Therapy in Growth Hormone Deficiency and Turner Syndrome Patients in Turkey. Journal of Clinical Research in Pediatric Endocrinology, Cilt: 8 - Sayı: 4, 490–495. https://ajindex.com/articles/216336

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Turkish Statistical Institute Population and Migration Statistics Group. Address based population registration system results 2015. Available at: http://www.turkstat.gov.tr Accessed March 2016.
  2. Haymond M, Kappelgaard AM, Czernichow P, Biller BM, Takano K, Kiess W; Global Advisory Panel Meeting on the Effects of Growth Hormone. Early recognition of growth abnormalities permitting early intervention. Acta Paediatr 2013;102:787-796. Epub 2013 May 13 Rogol AD, Hayden GF. Etiologies and early diagnosis of short stature and growth failure in children and adolescents. J Pediatr 2014;164(Suppl 5):1-14.
  3. De Onis M, Blössner M. WHO Global Database on Child Growth and Malnutrition. World Health Organization. Geneva, 1997. Available at: http://libdoc.who.int/hq/1997/WHO_NUT_97.4.pdf. Accessed May 2015. Hacettepe University Institute of Population Studies. Turkey Demographic and Health Survey 2008. Ankara, 2009. Available at: http://www.hips.hacettepe.edu.tr/eng/tdhs08/TDHS-2008_Main_ Report.pdf Accessed Dec 2015 Republic of Turkey Ministry of Health Turkish Public Health Institution, Department of Obesity, Diabetes and Metabolic Diseases Turkey Childhood (Ages 7-8) Obesity Surveillance Initiative (COSI-TUR) 2013. Ankara, 2014. Available at: http://www.halksagligiens.hacettepe.edu. tr/english/cosi_ing-2014.pdf Accessed Dec 2015 Raben MS. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 1958;18:901-903. Darendeliler F. Safety of growth hormone treatment. J Clin Res Ped Endo 2009;1(Suppl 1):36-43. Rosenbloom AL. Pediatric endo-cosmetology and the evolution of growth diagnosis and treatment. J Pediatr 2011;158:187-193. Epub 2010 Dec 18 2014;20:46-51.
  4. Backeljauw PF, Dattani MT, Cohen P, Rosenfeld RG. Disorders of growth hormone/insulin-like growth factor secretion and action. In: Sperling MA (ed). Pediatric Endocrinology. 4th edition. Philadelphia, Elsevier Saunders, 2014:292-404. Guyda HJ. Four decades of growth hormone therapy for short children: what have we achieved? J Clin Endocrinol Metab 1999;84:4307-4316. Turkish Pediatric Endocrinology and Diabetes Society webpage. Available at: www.cocukendokrindiyabet.org. Accessed Dec 2014. Ulusal Pediatrik Endokrinoloji Derneği. Çocukluk ve ergenlik döneminde büyüme hormonu eksikliği tanı ve tedavi uzlaşı raporu (Bölüm 1): Büyüme hormonu eksikliği tanısı. Çocuk Dergisi 2006;6:11- 16. (in Turkish) Bereket A, Özkan B, Kurtoğlu S. Turner sendromunda tanı ve tedavi: Ulusal Pediatrik Endokrinoloji De